| For: | Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 2012; 4(4): 87-95 [PMID: 22590662 DOI: 10.4240/wjgs.v4.i4.87] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v4/i4/87.htm |
| Number | Citing Articles |
| 1 |
Mengying Xu, Dan Liu, Le Wang, Shuangshuang Sun, Song Liu, Zhengyang Zhou. Clinical implications of CT-detected ascites in gastric cancer: association with peritoneal metastasis and systemic inflammatory response. Insights into Imaging 2024; 15(1) doi: 10.1186/s13244-024-01818-1
|
| 2 |
Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang, Jae-Joon Kim. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes. Cancers 2023; 15(8) doi: 10.3390/cancers15082383
|
| 3 |
Dongjing Jiang, Xun Liu, Rulan Tan, Ye Zhu, Li Zhang. Euphorbia factor L2 suppresses the generation of liver metastatic ascites in breast cancer via inhibiting NLRP3 inflammasome activation. International Journal of Molecular Medicine 2023; 53(1) doi: 10.3892/ijmm.2023.5332
|
| 4 |
Erin R Lane, Evelyn K Hsu, Karen F Murray. Management of ascites in children. Expert Review of Gastroenterology & Hepatology 2015; 9(10) doi: 10.1586/17474124.2015.1083419
|
| 5 |
Linda Calistri, Vieri Rastrelli, Cosimo Nardi, Davide Maraghelli, Sofia Vidali, Michele Pietragalla, Stefano Colagrande. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis. World Journal of Gastroenterology 2021; 27(46): 7866-7893 doi: 10.3748/wjg.v27.i46.7866
|
| 6 |
Shunya Hoshino, Yusuke Takagi, Takeo Fukagawa, Keiji Sano, Nobuhiko Seki, Yojiro Hashiguchi, Etsuko Aruga. Is Low Volume Drainage of Ascites Associated With Improved Survival in Digestive System Cancer Patients With Malignant Ascites?—A Retrospective Cohort Study. Journal of Palliative Care 2023; 38(4) doi: 10.1177/08258597231170049
|
| 7 |
L. Orgiano, F. Pani, G. Astara, C. Madeddu, S. Marini, A. Manca, Giovanni Mantovani. The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience. Supportive Care in Cancer 2016; 24(10) doi: 10.1007/s00520-016-3262-7
|
| 8 |
Tsae‐Jyy Wang, Hung‐Ming Wang, Tsai‐Sheng Yang, Sui‐Whi Jane, Tse‐Hung Huang, Chao‐Hui Wang, Yi‐Hsin Lin. The Effect of Abdominal Massage in Reducing Malignant Ascites Symptoms. Research in Nursing & Health 2015; 38(1) doi: 10.1002/nur.21637
|
| 9 |
Evangeline Mary Kiruba Samuel, Sudharsanan Sundaramurthi, Nandeesha Hanumanthappa, Vishnu Prasad Nelamangalaramakrishnaiah. Diagnostic value of vascular endothelial growth factor (VEGF) levels in gastrointestinal cancers with ascites - A cross sectional study. Turkish Journal of Surgery 2025; 41(1) doi: 10.47717/turkjsurg.2025.6592
|
| 10 |
Johan Fridegren, Linda Björkhem-Bergman, Torbjörn Schultz, Peter Strang. Ascites as a Predictive Factor in Malignancies in the Last Year of Life–Comparison Between Different Cancer Types. Journal of Palliative Medicine 2024; doi: 10.1089/jpm.2024.0140
|
| 11 |
Rongrui Liu, Rongbo Lin, Ning Li, Guiling Li, Tao Zhang, Jun Zhao, Jiayi Li, Meili Sun, Ke Wang, Hanxiang An, Weijie Zhang, Huiting Xu, Shan Zeng, Mingjun Zhang, Wei Duan, Yuxian Bai, Jingdong Zhang, He Tian, Fei Yin, Yu Kang, Qi Xu, Nong Xu, Yanhong Deng, Qing Chen, Yongqiang Li, Hongying Yang, Fang Su, Zhenghong Xiao, Xiaojun Xiang, Pengfei Zhou, Shaoyi Huang, Jing Zhang, Jianming Xu. Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00727-3
|
| 12 |
L Horvathova, B Mravec. Effect of the autonomic nervous system on cancer progression depends on the type of tumor: solid are more affected then ascitic tumors. Endocrine Regulations 2016; 50(4) doi: 10.1515/enr-2016-0023
|
| 13 |
|
| 14 |
Jeffrey Myers. Older Persons Experiencing Serious Illness. Physician Assistant Clinics 2026; 11(1) doi: 10.1016/j.cpha.2025.08.007
|
| 15 |
Kenny Zhuoran Wu, Rockie Haiyao Ding, Zixuan Zhao, Clara Yieh Lin Chong, Ruochii You, Hengjia Zhou, Dong Hua Seah, Wei Qiang Leow, Hong Kit Lim, Sukanya Shyamasundar, Kanishka Fernando, Fathima Farzana Kuthubudeen, Gillian Ng, Chor Yong Tay, Narayanan Gopalakrishna Iyer, Chin‐Ann Johnny Ong, Eliza Li Shan Fong. Hydrogel‐Mediated Preservation of Live Tumor Explants for Drug Development in Peritoneal Metastases. Advanced Materials 2025; 37(33) doi: 10.1002/adma.202418647
|
| 16 |
Mehmet Karahan, Emre Mat, Cemal Hacıalioğlu, Fatih Şanlıkan, Murat Levent Dereli, Pınar Birol İlter, Gazi Yıldız, Hasan Fehmi Küçük. vNOTES for Diagnostic Peritoneal Exploration in Peritoneal Carcinomatosis of Unknown Primary: A Prospective Pilot Feasibility Study. Surgical Innovation 2026; doi: 10.1177/15533506261476468
|
| 17 |
Kranthi Kumar Chougoni, Haemin Park, Priyadarshan K. Damle, Travis Mason, Bo Cheng, Martin M. Dcona, Barbara Szomju, Mikhail G. Dozmorov, Michael O. Idowu, Steven R. Grossman. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma. Oncogenesis 2023; 12(1) doi: 10.1038/s41389-023-00498-8
|
| 18 |
P. Mariani. Traitement symptomatique de la carcinose péritonéale. Côlon & Rectum 2020; 14(4) doi: 10.3166/cer-2020-0162
|
| 19 |
|
| 20 |
Feifei Zhang, Zhenning Feng, Yichi Zhang, Zishuai Liu, Xiaoli Sun, Shizhu Jin. Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites. Saudi Journal of Gastroenterology 2019; 25(5) doi: 10.4103/sjg.SJG_547_18
|
| 21 |
Junzi Zhang, Zhaoxue Qi, Wenjie Ou, Xuguang Mi, Yanqiu Fang, Wenqi Zhang, Zhen Yang, Ying Zhou, Xiuying Lin, Junjie Hou, Zhixin Yuan. Advances in the treatment of malignant ascites in China. Supportive Care in Cancer 2024; 32(2) doi: 10.1007/s00520-023-08299-w
|
| 22 |
Ipek Yonal, Asli Ciftcibasi, Suut Gokturk, Mustafa Nuri Yenerel, Filiz Akyuz, Cetin Karaca, Kadir Demir, Fatih Besisik, Sevgi Kalayoglu-Besisik. Massive Ascites as the Initial Manifestation of Mantle Cell Lymphoma: A Challenge for the Gastroenterologist. Case Reports in Gastroenterology 2012; 6(3) doi: 10.1159/000346290
|
| 23 |
Jamileh Jafari Mahdavi, Jale Aliasl, Mohammad Javad Ehsani, Mohammad Kamalinejad, Latif Gachkar, Rasool Choopani. Traditional Iranian medicine: The use of the Canon of medicine by Avicenna to treat ascites. European Journal of Integrative Medicine 2015; 7(6) doi: 10.1016/j.eujim.2015.08.009
|
| 24 |
C. F. Jehn, S. Küpferling, G. Oskay-Özcelik, D. Lüftner. A survey of treatment approaches of malignant ascites in Germany and Austria. Supportive Care in Cancer 2015; 23(7) doi: 10.1007/s00520-014-2557-9
|
| 25 |
Su-Min KIM, Yeonsu OH, Suk-Hun OH, Jeong-Hee HAN. Primary diffuse malignant peritoneal mesothelioma in a striped skunk (<i>Mephitis mephitis</i>). Journal of Veterinary Medical Science 2016; 78(3) doi: 10.1292/jvms.15-0377
|
| 26 |
|
| 27 |
Takafumi Segawa, Kenichi Kato, Kazuya Kawashima, Tomohiro Suzuki, Shigeru Ehara. The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function. Acta Radiologica Open 2018; 7(3) doi: 10.1177/2058460118764208
|
| 28 |
Weidong Jia, Zhiqiang Zhu, Tengyue Zhang, Gaofei Fan, Pingsheng Fan, Yabei Liu, Qiaohong Duan. Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil. Cancer Chemotherapy and Pharmacology 2013; 71(6) doi: 10.1007/s00280-013-2158-1
|
| 29 |
Tomokatsu Iwamura, Hideki Narumi, Tomohiko Suzuki, Hideyuki Yanai, Katsuyuki Mori, Koji Yamashita, Yoshiaki Tsushima, Tomomi Asano, Akiko Izawa, Shinobu Momen, Kazumi Nishimura, Hiromi Tsuchiyama, Masashi Uchida, Yuji Yamashita, Kiyoshi Okano, Tadatsugu Taniguchi. Novel pegylated interferon‐β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer. Cancer Science 2017; 108(4) doi: 10.1111/cas.13176
|
| 30 |
Nicholas Herodotou. Managing your Palliative Patient. British Journal of Hospital Medicine 2025; 86(2) doi: 10.12968/hmed.2024.0579
|
| 31 |
Sanne Bootsma, Maarten F Bijlsma, Louis Vermeulen. The molecular biology of peritoneal metastatic disease. EMBO Molecular Medicine 2023; 15(3) doi: 10.15252/emmm.202215914
|
| 32 |
Yan-li Zhu, Wen-hao Ren, Qian Wang, Hai-zhu Jin, Yi-yi Guo, Dong-mei Lin. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center. Diagnostic Pathology 2022; 17(1) doi: 10.1186/s13000-022-01241-4
|
| 33 |
David Wong, Ben Sykes, Nathan M. Slovis, Charles Brockus, Annette M. McCoy, Bettina Dunkel. Equine Neonatal Medicine. 2024; doi: 10.1002/9781119617228.ch17
|
| 34 |
James Jeffries, Matthew Gayed, Thuong G. Van Ha, Rakesh Navuluri. Management of Malignant Pleural Effusions and Malignancy-Related Ascites. Seminars in Interventional Radiology 2020; 37(04) doi: 10.1055/s-0040-1715885
|
| 35 |
Zhenhua Tian, Zhilong Huang, Yaqi Guo, Xiaolin Zhao, Luna Liu, Chunxiao Yu, Qingbo Guan. Risk factors for early readmission to hospital in patients with malignancy-related ascites: a retrospective cohort study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1409411
|
| 36 |
Alia Ghoneum, Hesham Afify, Ziyan Salih, Michael Kelly, Neveen Said. Role of tumor microenvironment in ovarian cancer pathobiology. Oncotarget 2018; 9(32) doi: 10.18632/oncotarget.25126
|
| 37 |
Liang Yik Lim, Robert Loneragan, Jessica Lee, Camilla Chan. Long-Term Peritoneal Indwelling Catheters for Malignant Ascites: A Retrospective Case Series of PleurX and Peritoneal Port. Journal of Palliative Medicine 2022; 25(7) doi: 10.1089/jpm.2021.0504
|
| 38 |
Hwee Leong Tan, Claramae Shulyn Chia, Grace Hwei Ching Tan, Su Pin Choo, David Wai-Meng Tai, Clarinda Wei Ling Chua, Matthew Chau Hsien Ng, Khee Chee Soo, Melissa Ching Ching Teo. Gastric peritoneal carcinomatosis - a retrospective review. World Journal of Gastrointestinal Oncology 2017; 9(3): 121-128 doi: 10.4251/wjgo.v9.i3.121
|
| 39 |
Dravya Jayakumar, KalpanaKumari Kasturi. Micronucleus and its significance in effusion fluids. Journal of Cytology 2020; 37(1) doi: 10.4103/JOC.JOC_42_19
|
| 40 |
Konstantinos Kamposioras, Joe Geraghty, Jordan Appleyard, Mohammed Dawod, Konstantinos Papadimitriou, Angela Lamarca, Alan Anthoney. Pancreaticobiliary Malignancies in the Emergency Room: Management of Acute Complications and Oncological Emergencies. Journal of Gastrointestinal Cancer 2022; 53(4) doi: 10.1007/s12029-021-00718-7
|
| 41 |
Revathy Nadhan, Danny N. Dhanasekaran. Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks. 2024; doi: 10.1016/B978-0-12-824040-3.00010-8
|
| 42 |
A. Chandramohan, A. Thrower, S.A. Smith, N. Shah, B. Moran. “PAUSE”: a method for communicating radiological extent of peritoneal malignancy. Clinical Radiology 2017; 72(11) doi: 10.1016/j.crad.2017.07.005
|
| 43 |
Hongsik Kim, Seung-Myoung Son, Chang Gok Woo, Ok-Jun Lee, Dae Hoon Kim, Hyo Yung Yun, Jieun Yun, Hee Kyung Kim, Yaewon Yang, Hye Sook Han. Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6035-0
|
| 44 |
Yingying Xu, Yuehong Kong, Yifu Ma, Meiling Xu, Jiabao Yang, Junjun Zhang, Rongzheng Chen, Guangqiang Chen, Zhihui Hong, Xiangrong Zhao, Chenyang Zhang, Pengfei Xing, Liyuan Zhang, Peifeng Zhao. Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study). Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241264169
|
| 45 |
Juan Camilo Correa, Alexandra M. Easson, Anand Govindarajan, Lucy Kathryn Helyer. Surgical Oncology Manual. 2016; doi: 10.1007/978-3-319-26276-5_18
|
| 46 |
Adriana C. Gamboa, Joshua H. Winer. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer. Cancers 2019; 11(11) doi: 10.3390/cancers11111662
|
| 47 |
Gonçalo Graça, Chung-Ho E. Lau, Luís G. Gonçalves. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1219 doi: 10.1007/978-3-030-34025-4_19
|
| 48 |
Ali Hussain, Qamar Iqbal, Sangeetha Isaac, Faisal Shariff, Ezza Tariq, Hassan Awais, Nayan Mainkar, Heidi Lynn Reis, Aakriti Arora, Akshay Deotare, Azka Tasleem, Srijan Valasapalli, Munizay Paracha, Maya Hashmi, Hamdi Battah, Mahvish Muzaffar. Efficacy and safety of trastuzumab deruxtecan in gastrointestinal malignancies: a systemic review and meta-analysis. Frontiers in Gastroenterology 2025; 4 doi: 10.3389/fgstr.2025.1559934
|
| 49 |
Olivia Ruhen, Katie Meehan. Tumor‐Derived Extracellular Vesicles as a Novel Source of Protein Biomarkers for Cancer Diagnosis and Monitoring. PROTEOMICS 2019; 19(1-2) doi: 10.1002/pmic.201800155
|
| 50 |
Kevin Korenblat. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; doi: 10.1016/B978-0-323-34062-5.00081-9
|
| 51 |
Radha Ramachandra Pai, Krithika Damodar Shenoy, Jessica Minal, Pooja K. Suresh, Shrijeet Chakraborti, Flora D. Lobo. Use of the term atypical cells in the reporting of ascitic fluid cytology: A caveat. CytoJournal 2019; 16 doi: 10.4103/cytojournal.cytojournal_37_18
|
| 52 |
Raquel Gerson Cwilich, Alejandro Zentella Dehesa, Héctor Murrieta González, Laura Daniela Campos Alvarado, Eric Alejandro García López, Christian Patricio Camacho Limas, Gabriela Olivia Regalado Porras, Jesús Miguel Lázaro León, Guillermo Manuel Olivares Beltrán, Juan Alberto Serrano Olvera, Alberto Villalobos Prieto, Diana Alejandra Villegas Osorno, Daniela Shveid Gerson, Alejandro Noguez Ramos. Sensibilidad in vitro a quimioterapia como posible herramienta de medicina personalizada en pacientes con cáncer y ascitis maligna. Iniciativa del Centro Médico ABC. Anales Médicos de la Asociación Médica del Centro Médico ABC 2021; 66(4) doi: 10.35366/102923
|
| 53 |
Laura A. Lambert, Ryan J. Hendrix. Palliative Management of Advanced Peritoneal Carcinomatosis. Surgical Oncology Clinics of North America 2018; 27(3) doi: 10.1016/j.soc.2018.02.008
|
| 54 |
Jae Hyun Kim, Seunghun Lee, Seung Hyun Lee, Byung Kwon Ahn, Sung Uhn Baek, Won Moon, Seun Ja Park. Clinical significance of carcinoembryonic antigen in peritoneal fluid detected during operation in stage I–III colorectal cancer patients. Intestinal Research 2018; 16(3) doi: 10.5217/ir.2018.16.3.467
|
| 55 |
Julia M. Berger, Matthias Preusser, Anna S. Berghoff, Elisabeth S. Bergen. Malignant ascites: Current therapy options and treatment prospects. Cancer Treatment Reviews 2023; 121 doi: 10.1016/j.ctrv.2023.102646
|
| 56 |
Xiahui Li, Zhe Yu, Liping Fang, Fang Liu, Kui Jiang. Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients. Medical Science Monitor 2017; 23 doi: 10.12659/MSM.899990
|
| 57 |
|
| 58 |
A. B. Villert, L. A. Kolomiets, N. V. Yunusova, A. A. Ivanova. Ascites as a subject of studies in ovarian cancer. Siberian journal of oncology 2019; 18(1) doi: 10.21294/1814-4861-2019-18-1-116-123
|
| 59 |
Yiqiu Wang, Yunting Sun, Xinyue Li, Xiaoli Yu, Keying Zhang, Jinglei Liu, Qingchang Tian, Honghua Zhang, Xiao Du, Shuling Wang. Progress in the treatment of malignant ascites. Critical Reviews in Oncology/Hematology 2024; 194 doi: 10.1016/j.critrevonc.2023.104237
|
| 60 |
Cristina Prata Amendola, Luís Gustavo Capochin Romagnolo, Raphael L. C. Araujo. Oncologic Critical Care. 2019; doi: 10.1007/978-3-319-74698-2_73-1
|
| 61 |
Piera Cote Robson, Mithat Gonen, Ai Ni, Lynn Brody, Karen T. Brown, George Getrajdman, Bridgette Thom, Nancy Kline, Anne Covey. Quality of life improves after palliative placement of percutaneous tunneled drainage catheter for refractory ascites in prospective study of patients with end-stage cancer. Palliative and Supportive Care 2019; 17(6) doi: 10.1017/S1478951519000051
|
| 62 |
Sana Ahuja, Avneesh Malviya. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy. Cytopathology 2022; 33(2) doi: 10.1111/cyt.13089
|
| 63 |
Solomon Liao, Rosene D. Pirrello, Rebecca Liddicoat Yamarik, Jamie Capasso. Gynecologic Oncology. 2015; doi: 10.1007/978-1-4939-1976-5_9
|
| 64 |
Yasuaki Arai, Miyuki Sone, Yoshito Takeuchi, Shunsuke Sugawara, Takeshi Aramaki, Toshihiro Tanaka, Mikio Sato, Shinichi Morita. Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study). Interventional Radiology 2026; 11(0) doi: 10.22575/interventionalradiology.2025-0091
|
| 65 |
Chuanxing Qu, Minzhi Xing, Anish Ghodadra, Kevin M. McCluskey, Ernesto Santos, Hyun S. Kim. The Impact of Tunneled Catheters for Ascites and Peritoneal Carcinomatosis on Patient Rehospitalizations. CardioVascular and Interventional Radiology 2016; 39(5) doi: 10.1007/s00270-015-1258-1
|
| 66 |
Ruchita Sachan, Anurag Gupta, Punit Namrata Awasthi, Pradyumn Singh, Nidhi Anand, Subrat Chandra, Gauri Gaur, Nuzhat Husain, Kumar Dheerendra Sachan. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting. Journal of the American Society of Cytopathology 2023; 12(5) doi: 10.1016/j.jasc.2023.04.005
|
| 67 |
Benson S. Chen, Stephen H. C. Wong, Stewart Hawkins, Linda Huggins. Permanent peritoneal ports for the management of recurrent malignant ascites: a retrospective review of safety and efficacy. Internal Medicine Journal 2018; 48(12) doi: 10.1111/imj.14137
|
| 68 |
Praneeth Suvvari, Abhijit Nair, Srinivasa Shyam Prasad Mantha, Mohammad Salman Saifuddin, Vibhavari Naik, Basanth Kumar Rayani. Management of Malignant Ascites by Indwelling Tunnelled Catheters in Indian Setup: A Case Series. Indian Journal of Palliative Care 2021; 27 doi: 10.25259/IJPC_416_20
|
| 69 |
Eleanor M. Scott, Sally Frost, Hena Khalique, Joshua D. Freedman, Len W. Seymour, Janet Lei-Rossmann. Oncolytic Viruses. Methods in Molecular Biology 2020; 2058 doi: 10.1007/978-1-4939-9794-7_17
|
| 70 |
Erin A. Strong, Austin Livingston, Maciej Gracz, Wendy Peltier, Susan Tsai, Kathleen Christians, T. Clark Gamblin, Karen Kersting, Callisia N. Clarke. Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?. Journal of Surgical Research 2022; 278 doi: 10.1016/j.jss.2022.04.012
|
| 71 |
Mariana Nunes, Sara Ricardo. Ovarian Cancer. 2022; doi: 10.36255/exon-publications-ovarian-cancer-malignant-ascites
|
| 72 |
Ramakrishnan Ayloor Seshadri, Olivier Glehen. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1114-1130 doi: 10.3748/wjg.v22.i3.1114
|
| 73 |
Christian Marth, Ignace Vergote, Giovanni Scambia, Willi Oberaigner, Andrew Clamp, Regina Berger, Christian Kurzeder, Nicoletta Colombo, Peter Vuylsteke, Domenica Lorusso, Marcia Hall, Vincent Renard, Sandro Pignata, Rebecca Kristeleit, Sevilay Altintas, Gordon Rustin, Robert M. Wenham, Mansoor Raza Mirza, Peter C. Fong, Amit Oza, Bradley J. Monk, Haijun Ma, Florian D. Vogl, Bruce A. Bach. ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer. European Journal of Cancer 2017; 70 doi: 10.1016/j.ejca.2016.09.004
|
| 74 |
Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy So, Wim Ceelen, Wei Peng Yong, Patrick Tan, Chin-Ann Johnny Ong, Raghav Sundar. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis. Journal of Clinical Oncology 2022; 40(24) doi: 10.1200/JCO.21.02745
|
| 75 |
Eiji Kasumi, Norifumi Sato. A ketogenic diet improves the prognosis in a mouse model of peritoneal dissemination without tumor regression. Journal of Clinical Biochemistry and Nutrition 2019; 64(3) doi: 10.3164/jcbn.18-103
|
| 76 |
Shijie Zhan, Mingo M. H. Yung, Michelle K. Y. Siu, Peili Jiao, Hextan Y. S. Ngan, David W. Chan, Karen K. L. Chan. New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232315263
|
| 77 |
Yusuke Kono, Shigeru Kawakami, Yuriko Higuchi, Kazuo Maruyama, Fumiyoshi Yamashita, Mitsuru Hashida. Antitumor effect of nuclear factor‐κB decoy transfer by mannose‐modified bubble lipoplex into macrophages in mouse malignant ascites. Cancer Science 2014; 105(8) doi: 10.1111/cas.12452
|
| 78 |
Radomir Živadinović, Aleksandra Petrić, Dane Krtinić, Sonja Pop-Trajković Dinić, Biljana Živadinović. Ascites - Physiopathology, Treatment, Complications and Prognosis. 2017; doi: 10.5772/intechopen.70476
|
| 79 |
Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler Curiel, Shelley A Dodt, Laura Doherty, Leisha A Emens, Claire F Friedman, Margaret Gatti-Mays, Melissa A Geller, Amir Jazaeri, Veena S John, Katherine C Kurnit, John B Liao, Haider Mahdi, Anne Mills, Emese Zsiros, Kunle Odunsi. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for ImmunoTherapy of Cancer 2023; 11(6) doi: 10.1136/jitc-2022-006624
|
| 80 |
|
| 81 |
Brittany P. Rickard, Christina Conrad, Aaron J. Sorrin, Mustafa Kemal Ruhi, Jocelyn C. Reader, Stephanie A. Huang, Walfre Franco, Giuliano Scarcelli, William J. Polacheck, Dana M. Roque, Marcela G. del Carmen, Huang-Chiao Huang, Utkan Demirci, Imran Rizvi. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers 2021; 13(17) doi: 10.3390/cancers13174318
|
| 82 |
ASCITES IN GASTROINTESTINAL CANCERS: A REVIEW OF SYMPTOMATIC TREATMENT METHODS AND THEIR EFFECTIVENESS. International Journal of Innovative Technologies in Social Science 2025; 4(3(47)) doi: 10.31435/ijitss.3(47).2025.4064
|
| 83 |
Zhaosheng Jin, Vincent Bargnes, Alexandra Tsivitis, Jonathan B. Oster, Jun Lin. Anesthesia for Oncological Surgery. 2023; doi: 10.1007/978-3-031-50977-3_71
|
| 84 |
Fang Liu, Xinjuan Kong, Qian Dou, J.i.n. Ye, Dong Xu, Haitao Shang, Keshu Xu, Yuhu Song. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Annals of Hepatology 2014; 13(3) doi: 10.1016/S1665-2681(19)30865-8
|
| 85 |
Andrew P. Koutnik, Angela M. Poff, Nathan P. Ward, Janine M. DeBlasi, Maricel A. Soliven, Matthew A. Romero, Paul A. Roberson, Carl D. Fox, Michael D. Roberts, Dominic P. D'Agostino. Ketone Bodies Attenuate Wasting in Models of Atrophy. Journal of Cachexia, Sarcopenia and Muscle 2020; 11(4) doi: 10.1002/jcsm.12554
|
| 86 |
Cristina Català, María Velasco-de Andrés, Sergi Casadó-Llombart, Alejandra Leyton-Pereira, Laura Carrillo-Serradell, Marcos Isamat, Francisco Lozano. Cellular Immunity in the Peritoneum. International Review of Cell and Molecular Biology 2022; 371 doi: 10.1016/bs.ircmb.2022.04.014
|
| 87 |
Paul-Andrei Ştefan, Andrei Lebovici, Csaba Csutak, Carmen Mihaela Mihu. Computed Tomography in the Diagnosis of Ascites: The Role of Fluid Attenuation Values. Current Medical Imaging Formerly Current Medical Imaging Reviews 2021; 17(3) doi: 10.2174/1573405616666200722152105
|
| 88 |
Ju-Hee Lee, Sung-Joon Kwon, Mimi Kim, Bo-Kyeong Kang. Prevalence and Clinical Implications of Ascites in Gastric Cancer Patients after Curative Surgery. Journal of Clinical Medicine 2021; 10(16) doi: 10.3390/jcm10163557
|
| 89 |
Chayanika Kala, Sanjay Kala, Anurag Singh, R. K. Jauhari, Ashutosh Bajpai, Lubna Khan. The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology. Journal of Cytology 2023; 40(4) doi: 10.4103/joc.joc_111_22
|
| 90 |
Ken Masuda, Hiroto Ishiki, Naosuke Yokomichi, Takuhiro Yamaguchi, Tetsuya Ito, Hana Takatsu, Koji Amano, Shuji Hiramoto, Toshihiro Yamauchi, Takashi Kawaguchi, Masanori Mori, Yosuke Matsuda, Takashi Yamaguchi. Effect of paracentesis on the survival of patients with terminal cancer and ascites: a propensity score–weighted analysis of the East Asian Collaborative Cross-cultural Study to Elucidate the Dying Process. Supportive Care in Cancer 2022; 30(7) doi: 10.1007/s00520-022-07057-8
|
| 91 |
Gordon T. Moffat, Andrew S. Epstein, Eileen M. O'Reilly. Pancreatic cancer—A disease in need: Optimizing and integrating supportive care. Cancer 2019; 125(22) doi: 10.1002/cncr.32423
|
| 92 |
Yu-Wen Sung, Yun-Shan Lin, Yen-Ting Chen, Lian-Shung Yeh. Non-Hodgkin's B-cell lymphoma of the ovary: A case report and review of the literature. Taiwanese Journal of Obstetrics and Gynecology 2022; 61(3) doi: 10.1016/j.tjog.2022.03.026
|
| 93 |
Huma Quanungo, Huda Quanungo, Elena Naderzad, Frederick Venter, Elaine Deemer, Greti Petersen, Alan Ragland. A Rare Hemorrhagic, Orange-Colored Ascites, Challenging Traditional Ascitic Fluid Analysis. Journal of Investigative Medicine High Impact Case Reports 2023; 11 doi: 10.1177/23247096221150630
|
| 94 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2018; doi: 10.1007/978-3-319-33434-9_21
|
| 95 |
Arnoud W. Kastelein, Laura M.C. Vos, Kees H. de Jong, Juliette O.A.M. van Baal, Rienk Nieuwland, Cornelis J.F. van Noorden, Jan-Paul W.R. Roovers, Christianne A.R. Lok. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Seminars in Cell & Developmental Biology 2019; 92 doi: 10.1016/j.semcdb.2018.09.007
|
| 96 |
Ninad Katdare, Robin Prabhu, Aditi Bhatt. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; doi: 10.1007/978-981-10-7053-2_22
|
| 97 |
Vincent Gamblin, Arlette Da Silva, Stéphanie Villet, Farid El Hajbi. Prise en charge symptomatique de l’ascite maligne en phase palliative : place de la paracentèse et des diurétiques. Bulletin du Cancer 2015; 102(11) doi: 10.1016/j.bulcan.2015.09.002
|
| 98 |
Sahar J. Farahani, Zubair Baloch. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagnostic Cytopathology 2019; 47(11) doi: 10.1002/dc.24278
|
| 99 |
Pompiliu Piso, Hubert Leebmann. Palliative Viszeralchirurgie. 2019; doi: 10.1007/978-3-662-57362-4_24
|
| 100 |
Adrian Kohut, Mary Cathryn Earnhardt, Nicholas G. Cuccolo, Chi-Son Kim, Mihae Song, Eugenia Girda, Alexandre Buckley De Meritens, Ruth Stephenson, Adrian Balica, Aliza Leiser, Kitaw Demissie, Lorna Rodriguez-Rodriguez. Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer. Gynecologic Oncology 2020; 156(1) doi: 10.1016/j.ygyno.2019.08.023
|
| 101 |
Säde Korpi, Veera V. Salminen, Reetta P. Piili, Niina Paunu, Tiina Luukkaala, Juho T. Lehto. Therapeutic Procedures for Malignant Ascites in a Palliative Care Outpatient Clinic. Journal of Palliative Medicine 2018; 21(6) doi: 10.1089/jpm.2017.0616
|
| 102 |
Wasat Mansoor, Eric J. Roeland, Aafia Chaudhry, Astra M. Liepa, Ran Wei, Holly Knoderer, Paolo Abada, Anindya Chatterjee, Samuel J. Klempner. Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies. The Oncologist 2021; 26(9) doi: 10.1002/onco.13836
|
| 103 |
Tieyun Guo, Jiade Li, Jing Li, Dan Kong, Chunli Bi, Zheng He, Dai Tang, Xiaoming Jin, Lianhong Jin. Association between hyperpolarization-activated channel in interstitial cells of Cajal and gastrointestinal dysmotility induced by malignant ascites. Oncology Letters 2017; 13(3) doi: 10.3892/ol.2017.5652
|
| 104 |
Vishal Sharma, Daya Krishna Jha, Manish Rohilla, Chandan K Das, Harjeet Singh, Santhosh Irrinki, Aashima Arora, Subhas C Saha, Pankaj Gupta, Harshal S Mandavdhare, Usha Dutta, Aman Sharma. ‘Rollover’ Abdominal Paracentesis Versus Standard Technique: Protocol of a Crossover Randomized Comparative Trial. Future Oncology 2021; 17(26) doi: 10.2217/fon-2020-1050
|
| 105 |
K. Daga, T. Berry, D. Mullan, H.-U. Laasch. Transformation of indwelling peritoneal catheter placement for malignant ascites from an inpatient to a day-case service: analysis of patient risk and financial implication. Clinical Radiology 2022; 77(9) doi: 10.1016/j.crad.2022.05.027
|
| 106 |
Hyunsik Bae, Hyunjin Kim, Jinah Chu, Yunjeong Jang, Hyun Hee Koh, Hera Jung, Sang Yun Ha, Kee-Taek Jang, Kyoung-Mee Kim. Pathologic analyses of peritoneal nodules in gastric cancer patients during surgery—A single cancer center experience with diagnostic pitfalls. Pathology - Research and Practice 2019; 215(1) doi: 10.1016/j.prp.2018.11.013
|
| 107 |
Amir Parray, Vikas Gupta, Vikram A. Chaudhari, Shailesh V. Shrikhande, Manish S. Bhandare. Role of intraperitoneal chemotherapy in gastric cancer. Surgery in Practice and Science 2021; 4 doi: 10.1016/j.sipas.2020.100025
|
| 108 |
Fiona Unaç, Jennifer Sexton. Radiology Nurse-Led Ascites Drainage Service in a Community Hospice. Journal of Radiology Nursing 2018; 37(1) doi: 10.1016/j.jradnu.2017.11.005
|
| 109 |
Francyelli Mello-Andrade, Wanderson Lucas da Costa, Wanessa Carvalho Pires, Flávia de Castro Pereira, Clever Gomes Cardoso, Ruy de Souza Lino-Junior, Vicente Raul Chavarria Irusta, Cristiene Costa Carneiro, Paulo Roberto de Melo-Reis, Carlos Henrique Castro, Marcio Aurélio Pinheiro Almeida, Alzir Azevedo Batista, Elisângela de Paula Silveira-Lacerda. Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression. Tumor Biology 2017; 39(10) doi: 10.1177/1010428317695933
|
| 110 |
S. Bauones, R.L. Cazzato, D. Dalili, G. Koch, J. Garnon, J. Gantzer, J.E. Kurtz, A. Gangi. Precision pain management in interventional radiology. Clinical Radiology 2023; 78(4) doi: 10.1016/j.crad.2022.09.135
|
| 111 |
Allison M. Dyevoich, Karen M. Haas. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Molecular Cancer Therapeutics 2020; 19(6) doi: 10.1158/1535-7163.MCT-19-0885
|
| 112 |
Jilke De Wilde, Ruben Van Paemel, Andries De Koker, Sofie Roelandt, Sofie Van de Velde, Nico Callewaert, Jo Van Dorpe, David Creytens, Bram De Wilde, Katleen De Preter. A Fast, Affordable, and Minimally Invasive Diagnostic Test for Cancer of Unknown Primary Using DNA Methylation Profiling. Laboratory Investigation 2024; 104(8) doi: 10.1016/j.labinv.2024.102091
|
| 113 |
Angel Mier Hicks, Joanne Chou, Marinela Capanu, Maeve A. Lowery, Kenneth H. Yu, Eileen M. O'Reilly. Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. Clinical Colorectal Cancer 2016; 15(4) doi: 10.1016/j.clcc.2016.04.014
|
| 114 |
Annarita Farina. Proximal fluid proteomics for the discovery of digestive cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2014; 1844(5) doi: 10.1016/j.bbapap.2013.10.011
|
| 115 |
Weimin He, Xia He, Zhi Qiao, Yongsheng Wang. Emerging immunotherapeutic strategies for malignant serous effusions: current evidence and future directions. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1757825
|
| 116 |
Yuki Hashimoto, Norihiko Inoue, Shinobu Imai. Clinical Outcomes and Healthcare Costs of CART Versus Paracentesis for Malignant Ascites: A Nationwide Retrospective Cohort Study in Japan. Cancer Medicine 2026; 15(1) doi: 10.1002/cam4.71491
|
| 117 |
|
| 118 |
Ann-Cathrine Siefen, Leonie Eilers, Christoph T. Baltin, Florian Kron. Cost Comparison of Treatment Alternatives for Pleural Effusion and Ascites from a Payer Perspective: Are There Cost Savings from Indwelling Catheters?. Journal of Palliative Medicine 2023; 26(11) doi: 10.1089/jpm.2022.0592
|
| 119 |
O. I. Aleshikova, N. A. Babaeva, E. V. Gerfanova, I. B. Antonova, V. O. Shender, A. E. Babaeva, L. A. Ashrafyan. Ovarian cancer, malignant ascites and microenvironment. Literature review. Sechenov Medical Journal 2023; 14(2) doi: 10.47093/2218-7332.2023.14.2.21-30
|
| 120 |
Ying Liu, Clara Yieh Lin Chong, Yingrui Wang, Luang Xu, Hui Jun Lim, Qiu Xuan Tan, Josephine Hendrikson, Joey Wee-Shan Tan, Gillian Ng, Wanyu Guo, Youming Wang, Lingling Huang, Weigang Ge, Vinoth Kumar Rethineswaran, Jolynn Zu Lin Ong, Ying En Quek, Andre Jing Yuen Ang, Fionicca Teo, Oris Wanyi Chen, Ananya Rajesh, Yuwei Zhang, Tun Kiat Ko, Bavani Kannan, Boon Yee Lim, Elizabeth Chun Yong Lee, Zexi Guo, Vairavan Lakshmanan, Nicholas Brian Shannon, Nagalakshmi Jegannathan, Craig Ryan Joseph, Zhen Wei Neo, Li Yen Chong, Amanda R. H. Ng, Jia-Ying Joey Lee, Lit-Hsin Loo, Yang Wu, Siyu Zhang, Lanqi Nie, Qiqi Zhang, Lei Zeng, Tony Kiat Hon Lim, Matthew Chau Hsien Ng, Christabel Jing Zhi Lee, Pik Eu Jason Chang, Kevin Kim-Jun Teh, Hiang Keat Tan, Ravichandran Nadarajah, Tze Tein Yong, Junjie Wang, Ieera Madan Aggarwal, Eliza Li Shan Fong, Kenny Zhuoran Wu, Jimmy Bok Yan So, Khay Guan Yeoh, Jolene Si Min Wong, Chin Jin Seo, Mingzhe Cai, Claramae Shulyn Chia, Bin Tean Teh, Iain Beehuat Tan, Joe Yeong, Jason Yongsheng Chan, Tiannan Guo, Chin-Ann Johnny Ong. Identification of novel paracrine therapeutic targets in peritoneal metastases through integrative proteotranscriptomic analysis of ascites. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-026-02787-3
|
| 121 |
Joseph Caldwell, Hawa Edriss, Kenneth Nugent. Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites. Baylor University Medical Center Proceedings 2018; 31(3) doi: 10.1080/08998280.2018.1461525
|
| 122 |
Jie Dai, Renjin Chen, Jie Wang, Ping Zhou, Biqiong Wang, Jianmei Li, Yun Lu, Xianlun Pang, Shaozhi Fu. Intraperitoneal administration of doxorubicin-encapsulated Brucea javanica oil nanoemulsion against malignant ascites. European Journal of Pharmaceutics and Biopharmaceutics 2024; 202 doi: 10.1016/j.ejpb.2024.114422
|
| 123 |
Lisa M. Rooper, Syed Z. Ali, Matthew T. Olson. A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases. Journal of the American Society of Cytopathology 2016; 5(5) doi: 10.1016/j.jasc.2016.04.004
|
| 124 |
Shan-shan Su, Guo-qi Zheng, Wen-jie Yin, Yu-fei Liang, Ying-ying Liu, Hui Song, Ning-ning Sun, Yu-xin Yang. Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis. Gastroenterology Research and Practice 2018; 2018 doi: 10.1155/2018/2619526
|
| 125 |
Golo Petzold, Gesine Graw, Fani Delistefani, Richard Friedemann Knoop, André Sasse, Volker Ellenrieder, Albrecht Neesse, Ahmad Amanzada. Safety and effectiveness of transient ascites drainage in hospitalized patients with large ascites. European Journal of Gastroenterology & Hepatology 2025; 37(12) doi: 10.1097/MEG.0000000000003038
|
| 126 |
Sergio Miravent, Némis Q Garcia, Inês N Gregório, Bruna S Vaz, Manuel D Lobo, Rui P Almeida. Screening Sonography in the Prehospital Setting: A Case Report on Transforming Clinical Decisions. Cureus 2025; doi: 10.7759/cureus.91871
|
| 127 |
J.M. Berger, A. Alany, R. Puhr, L. Berchtold, A. Friedrich, B. Scheiner, G.W. Prager, A.S. Berghoff, M. Preusser, E.S. Bergen. Clinical risk factors for ascites in metastatic pancreatic cancer. ESMO Open 2023; 8(2) doi: 10.1016/j.esmoop.2023.101200
|
| 128 |
Caroline Poisson, Anda Sampetrean, Perrine Renard, Rita-Maria Khoury-Abboud, Florian Scotté, Laurence Vigouret-Viant, Baptiste Bonnet, Lambros Tselikas, Frédéric Deschamps, Christine Mateus. Palliative semi-permanent abdominal drain for the management of refractory malignant ascites: a retrospective study in a comprehensive cancer center. Supportive Care in Cancer 2025; 33(6) doi: 10.1007/s00520-025-09551-1
|
| 129 |
Jim Cassidy, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff. Oxford Handbook of Oncology. 2015; doi: 10.1093/med/9780199689842.003.0003
|
| 130 |
Vishal K. Gupta, Michael Dennis, Emily Mann, Joseph O. Jacobson, Naomi Y. Ko. Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO Oncology Practice 2021; 17(3) doi: 10.1200/OP.20.00593
|
| 131 |
Paige O. Mirsky, Patrick L. Wagner, Maja Mandic-Popov, Vera S. Donnenberg, Albert D. Donnenberg. The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy. Cancers 2025; 17(19) doi: 10.3390/cancers17193217
|
| 132 |
Selene Meza-Perez, Troy D. Randall. Immunological Functions of the Omentum. Trends in Immunology 2017; 38(7) doi: 10.1016/j.it.2017.03.002
|
| 133 |
Yan Yan, Yukun Wang, Yiru Da, Yongjun Piao. Single-cell RNA sequencing analysis reveals transcriptional dynamics of immune cells during ovarian cancer metastasis. 2024 IEEE 9th International Conference on Data Science in Cyberspace (DSC) 2024; doi: 10.1109/DSC63484.2024.00115
|
| 134 |
Tatiana Zamay, Sergey Zamay, Natalia Luzan, Victoriya Fedotovskaya, Albert Masyugin, Fyodor Zelenov, Anastasia Koshmanova, Elena Nikolaeva, Daria Kirichenko, Dmitry Veprintsev, Olga Kolovskaya, Irina Shchugoreva, Galina Zamay, Ivan Lapin, Anna Lukyanenko, Andrey Borus, Alexander Sukhachev, Mikhail Volochaev, Kirill Lukyanenko, Alexandr Shabanov, Vladimir Zabluda, Alexey Zhizhchenko, Aleksandr Kuchmizhak, Alexey Sokolov, Andrey Narodov, Vladimir Prokopenko, Rinat Galeev, Valery Svetlichnyi, Anna Kichkailo. Magnetic Nanoscalpel for the Effective Treatment of Ascites Tumors. Journal of Functional Biomaterials 2023; 14(4) doi: 10.3390/jfb14040179
|
| 135 |
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Annals of Surgical Oncology 2020; 27(6) doi: 10.1245/s10434-020-08323-x
|
| 136 |
Maria Jung, Svenja Pützer, Heidrun Gevensleben, Sebastian Meller, Glen Kristiansen, Dimo Dietrich. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0192-7
|
| 137 |
|
| 138 |
Govindarajan Narayanan, Amir Pezeshkmehr, Shree Venkat, Gabriella Guerrero, Katuzka Barbery. Safety and Efficacy of the PleurX Catheter for the Treatment of Malignant Ascites. Journal of Palliative Medicine 2014; 17(8) doi: 10.1089/jpm.2013.0427
|
| 139 |
Olimpia Sipak-Szmigiel, Piotr Włodarski, Elżbieta Ronin-Walknowska, Andrzej Niedzielski, Beata Karakiewicz, Sylwia Słuczanowska-Głąbowska, Maria Laszczyńska, Witold Malinowski. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies. Journal of Ovarian Research 2017; 10(1) doi: 10.1186/s13048-017-0320-9
|
| 140 |
Srishti Kashyap, Revathy Nadhan, Muralidharan Jayaraman, Rohini Gomathinayagam, Ji Hee Ha, Danny N. Dhanasekaran. Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks. 2024; doi: 10.1016/B978-0-12-824040-3.00013-3
|
| 141 |
Laura A. Lambert, Jason Wiseman. Palliative Management of Peritoneal Metastases. Annals of Surgical Oncology 2018; 25(8) doi: 10.1245/s10434-018-6335-7
|
| 142 |
А. Ю. Конишева, С. Д. Мясоєдов. Структура симптоматичного навантаження у хворих на метастатичний рак органів травлення. Likarska sprava 2026; (2) doi: 10.31640/LS-2026-2-01
|
| 143 |
Ricardo Coelho, Sara Ricardo, Ana Luísa Amaral, Yen-Lin Huang, Mariana Nunes, José Pedro Neves, Nuno Mendes, Mónica Nuñez López, Carla Bartosch, Verónica Ferreira, Raquel Portugal, José Manuel Lopes, Raquel Almeida, Viola Heinzelmann-Schwarz, Francis Jacob, Leonor David. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis 2020; 9(6) doi: 10.1038/s41389-020-00246-2
|
| 144 |
Marie-France Penet, Balaji Krishnamachary, Flonné B. Wildes, Yelena Mironchik, Chien-Fu Hung, TC Wu, Zaver M. Bhujwalla. Ascites Volumes and the Ovarian Cancer Microenvironment. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00595
|
| 145 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2017; doi: 10.1007/978-3-319-32700-6_21-1
|
| 146 |
Anuradha Chandramohan, Nehal Shah, Andrew Thrower, Norman John Carr, Rohin Mittal, Faheez Mohamed, Brendan Moran. Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making. Insights into Imaging 2021; 12(1) doi: 10.1186/s13244-021-01118-y
|
| 147 |
Stefano Guglielmi, Gabriel Guglielmi, Romain Breguet, Geneviève Gridel. Intérêt d’un cathéter péritonéal semi-permanent dans la prise en charge de l’ascite maligne en situation palliative avancée. Revue internationale de soins palliatifs 2015; (1) doi: 10.3917/inka.151.0025
|
| 148 |
Mona Passler, Maximilian Krafft, Eliane Tabea Taube, Jalid Sehouli, Klaus Pietzner. Aktuelle Therapiestrategien bei malignem Aszites. Im Focus Onkologie 2017; 20(12) doi: 10.1007/s15015-017-3667-2
|
| 149 |
Richa Bhardwaj, Haleh Vaziri, Arun Gautam, Enrique Ballesteros, David Karimeddini, George Y. Wu. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. Journal of Clinical and Translational Hepatology 2018; 6(1) doi: 10.14218/JCTH.2017.00035
|
| 150 |
Oumer Abdu Muhie. Causes and Clinical Profiles of Ascites at University of Gondar Hospital, Northwest Ethiopia: Institution-Based Cross-Sectional Study. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/5958032
|
| 151 |
Qingchang Chen, Yan Zhang, Auginia Natalia, Jun Zhou, Zhonglang Yu, Xianguang Ding, Chin-Ann J. Ong, Jimmy B. Y. So, Huilin Shao. Catalytic profiling of extracellular vesicles maps altered cancer metabolism. Nature Nanotechnology 2026; 21(9) doi: 10.1038/s41565-026-02230-0
|
| 152 |
Kotaro Takeda, Catherine Gereg, Xiaoying Liu, Weijie Ma, Mayara Bearse, Haiming Tang, Isabela Delfino, Eric Huang, Xiaoqi Lin, Jocelyn B. Chandler, He Wang. Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false‐negative cytology: A multi‐institutional analysis. Cytopathology 2025; 36(1) doi: 10.1111/cyt.13447
|
| 153 |
Matthias Hornung, Jens M. Werner, Hans J. Schlitt. Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Expert Review of Anticancer Therapy 2017; 17(9) doi: 10.1080/14737140.2017.1357470
|
| 154 |
Shruti Gupta, Gearoid M. McMahon, Shveta S. Motwani, David B. Mount, Sushrut S. Waikar. “Pleurex Desalination” in Malignancy-related Ascites. American Journal of Clinical Oncology 2020; 43(1) doi: 10.1097/COC.0000000000000618
|
| 155 |
Irene van der Haar Àvila, Kristiaan Lenos, Victor Lorrain, Eleonora Nardini, Ernesto Rodríguez, Juan J. García‐Vallejo, Yvette van Kooyk, Joep Grootjans, Sandra J. van Vliet. Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site. European Journal of Immunology 2026; 56(5) doi: 10.1002/eji.70204
|
| 156 |
Bradley J. Monk, Andrés Poveda, Ignace Vergote, Francesco Raspagliesi, Keiichi Fujiwara, Duk-Soo Bae, Ana Oaknin, Isabelle Ray-Coquard, Diane M. Provencher, Beth Y. Karlan, Catherine Lhommé, Gary Richardson, Dolores Gallardo Rincón, Robert L. Coleman, Christian Marth, Arija Brize, Michel Fabbro, Andrés Redondo, Aristotelis Bamias, Haijun Ma, Florian D. Vogl, Bruce A. Bach, Amit M. Oza. Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2. Gynecologic Oncology 2016; 143(1) doi: 10.1016/j.ygyno.2016.07.112
|
| 157 |
Caitlin Hodge, Brian D. Badgwell. Palliation of malignant ascites. Journal of Surgical Oncology 2019; 120(1) doi: 10.1002/jso.25453
|
| 158 |
Oliver Hunsicker, Christina Fotopoulou, Klaus Pietzner, Mandy Koch, Alexander Krannich, Jalid Sehouli, Claudia Spies, Aarne Feldheiser. Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*. Medicine 2015; 94(49) doi: 10.1097/MD.0000000000002108
|
| 159 |
Michael Carranza, Michael Chahin, Anwer Siddiqi, Jeff House. Malignant eosinophilic ascites due to metastatic urothelial carcinoma with peritoneal carcinomatosis. BMJ Case Reports 2020; 13(12) doi: 10.1136/bcr-2020-238530
|
| 160 |
Aditi Bhatt, Sanket Mehta. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; doi: 10.1007/978-981-10-7053-2_3
|
| 161 |
Amirabbas Parizadeh, Shruti Warhadpande, Mark Jesus M. Magbanua, Jennifer M. Rosenbluth. Circulating Tumor Cells. Methods in Molecular Biology 2026; 2999 doi: 10.1007/978-1-0716-5050-9_22
|
| 162 |
Jonas Leichsenring, Anna‐Lena Volckmar, Martina Kirchner, Daniel Kazdal, Mark Kriegsmann, Fabian Stögbauer, Teresa Bockmayr, Frederick Klauschen, Felix J.F. Herth, Roland Penzel, Arne Warth, Peter Schirmacher, Volker Endris, Albrecht Stenzinger. Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Genes, Chromosomes and Cancer 2018; 57(2) doi: 10.1002/gcc.22509
|
| 163 |
Chengtao Wen, Qiaohong Duan, Tengyue Zhang, Yabei Liu, Yang Wu, Kelong Ma, Pingsheng Fan, Weidong Jia. Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy. Cancer Chemotherapy and Pharmacology 2014; 74(3) doi: 10.1007/s00280-014-2532-7
|
| 164 |
Danny Ngo, Jemianne Bautista Jia, Christopher S. Green, Anjalie T. Gulati, Chandana Lall. Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights into Imaging 2015; 6(6) doi: 10.1007/s13244-015-0436-7
|
| 165 |
Chelsey C Ciambella, Rachel E Beard, Thomas J Miner. Current role of palliative interventions in advanced pancreatic cancer. World Journal of Gastrointestinal Surgery 2018; 10(7): 75-83 doi: 10.4240/wjgs.v10.i7.75
|
| 166 |
Ilias P. Nikas, Sojung Lim, Seock-Ah Im, Kyung-Hun Lee, Dae-Won Lee, Hyebin Lee, Han Suk Ryu. Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers. Pathobiology 2024; 91(3) doi: 10.1159/000533912
|
| 167 |
Mustafa Kemal Ruhi, Brittany P. Rickard, William J. Polacheck, Imran Rizvi. Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer. 2023; doi: 10.5772/intechopen.106725
|
| 168 |
Paul Carrier, Marilyne Debette-Gratien, Jérémie Jacques, Véronique Loustaud-Ratti. Non-Cirrhotic Ascites: Causes and Management. Gastroenterology Insights 2024; 15(4) doi: 10.3390/gastroent15040065
|
| 169 |
Kevin A. Bohn, Charles E. Ray. Repeat Large-Volume Paracentesis Versus Tunneled Peritoneal Catheter Placement for Malignant Ascites: A Cost-Minimization Study. American Journal of Roentgenology 2015; 205(5) doi: 10.2214/AJR.15.14484
|
| 170 |
Caitlin Hodge, Brian Badgwell. Oncologic Emergency Medicine. 2021; doi: 10.1007/978-3-030-67123-5_59
|
| 171 |
Xiao Wu, Eric J. Keller, Rana Rabei, Helena Rockwell, Summer Beeson, Michael Heller, Nishita Kothary. Cost-effectiveness of tunneled peritoneal catheters versus repeat paracenteses for recurrent ascites in gynecologic malignancies. Gynecologic Oncology 2022; 164(3) doi: 10.1016/j.ygyno.2022.01.011
|
| 172 |
Lucía Pascual-Antón, Beatriz Cardeñes, Ricardo Sainz de la Cuesta, Lucía González-Cortijo, Manuel López-Cabrera, Carlos Cabañas, Pilar Sandoval. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer. International Journal of Molecular Sciences 2021; 22(21) doi: 10.3390/ijms222111496
|
| 173 |
Sisi Deng, Wooyong Kim, Kefan Cheng, Qianlu Yang, Yogesh Singh, Gyuntae Bae, Nicolas Bézière, Lukas Mager, Stefan Kommoss, Jannik Sprengel, Christoph Trautwein. Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer. Cancer & Metabolism 2025; 13(1) doi: 10.1186/s40170-025-00391-5
|
| 174 |
Tomohiro Ito, Makoto Hamasaki, Shinji Matsumoto, Kenzo Hiroshima, Tohru Tsujimura, Toshiaki Kawai, Yoshiya Shimao, Kousuke Marutsuka, Sayaka Moriguchi, Riruke Maruyama, Shingo Miyamoto, Kazuki Nabeshima.
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer. American Journal of Clinical Pathology 2015; 143(6) doi: 10.1309/AJCPOATJ9L4GCGDA
|
| 175 |
Ayako Shiraki, Shino Ito, Dai Muramatsu, Tomoki Sasaki, Akira Otsuka, Tomomi Miyahara, Katsuya Takahashi, Keiji Yoshioka, Miki Suehiro. Non-clinical safety of novel cross-linked chondroitin sulfate (SI-449) as an anti-adhesion barrier for abdominal and pelvic surgeries. Journal of Biomaterials Applications 2026; 41(4) doi: 10.1177/08853282261432825
|
| 176 |
Beatriz Cardeñes, Irene Clares, Tamara Bezos, Víctor Toribio, Soraya López-Martín, Almudena Rocha, Héctor Peinado, María Yáñez-Mó, Carlos Cabañas. ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles. International Journal of Molecular Sciences 2022; 23(10) doi: 10.3390/ijms23105753
|
| 177 |
Jens Krugmann, Corinna Lang Schwarz, Balint Melcher, William Sterlacci, Michael Vieth, Sophia Rösch, Johannes Lermann. Diagnostic impact of ascites cytology in 941 patients: malignancy rates and time of detection in ovarian cancer relative to other tumor types. Archives of Gynecology and Obstetrics 2020; 301(6) doi: 10.1007/s00404-020-05553-y
|
| 178 |
Vivian P. Bastiaenen, Charlotte E.L. Klaver, Maartje C.S. van der Heijden, Lisanne E. Nijman, Maria C. Lecca, Pieter J. Tanis, Kristiaan J. Lenos, Louis Vermeulen. A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity. Laboratory Investigation 2020; 100(11) doi: 10.1038/s41374-020-0448-x
|
| 179 |
Hae Moon, Hak Jin Kim, Sang Myung Woo, In Hae Park, Sung Hoon Sim. Discrimination of ascitic fluid infection in malignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm3 as the one‐size‐fits‐all criterion. Asia-Pacific Journal of Clinical Oncology 2021; 17(2) doi: 10.1111/ajco.13344
|
| 180 |
Ghada Ali AboElfath Sheta, Mariam Raafat, Radwa Mahmoud Abdallah, Eman Khaled Mahmoud, Yasmin Essameldin Abdalla Khalifa. Preoperative evaluation of peritoneal carcinomatosis in primary gynecologic malignancies: MRI versus MDCT using the PAUSE-based reporting system. Egyptian Journal of Radiology and Nuclear Medicine 2026; 57(1) doi: 10.1186/s43055-026-01830-z
|
| 181 |
Aurélien Proux, Yanis Dahel, Alexandre de Nonneville, Géraldine Capodano, Nathalie Ramirez, Anne-Deborah Bouhnik, Vanessa Collin, Michaël Dassa, Nassima Daidj. Safety and Prognostic Factor for Survival in Patients with PleurX Drain for Malignant Ascites: AscitX Study. Journal of Palliative Medicine 2024; doi: 10.1089/jpm.2024.0217
|
| 182 |
Hiromichi Maeda, Michiya Kobayashi, Junichi Sakamoto. Evaluation and treatment of malignant ascites secondary to gastric cancer. World Journal of Gastroenterology 2015; 21(39): 10936-10947 doi: 10.3748/wjg.v21.i39.10936
|
| 183 |
Tuğba Ocak, Macit Gülten. Retrospective Investigation of Factors Affecting Mortality in Spontaneous Bacterial Peritonitis. Euroasian Journal of Hepato-Gastroenterology 2023; 13(1) doi: 10.5005/jp-journals-10018-1387
|
| 184 |
Hao Chen, Masashi Ishihara, Nobuyuki Horita, Shigeru Tanzawa, Hiroki Kazahari, Ryusuke Ochiai, Takahiko Sakamoto, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki. Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis. Cancers 2021; 13(19) doi: 10.3390/cancers13194873
|
| 185 |
Soo‐Ryum Yang, Kelly L. Mooney, Paolo Libiran, Carol D. Jones, Rohan Joshi, Hubert D. Lau, Henning Stehr, Gerald J. Berry, James L. Zehnder, Steven R. Long, Christina S. Kong, Christian A. Kunder. Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathology 2020; 128(1) doi: 10.1002/cncy.22205
|
| 186 |
Laine Celestino Pinto, Caroline de Fátima Aquino Moreira-Nunes, Bruno Moreira Soares, Rommel Mário Rodriguez Burbano, José Alexandre Rodrigues de Lemos, Raquel Carvalho Montenegro. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis. Toxicology in Vitro 2017; 43 doi: 10.1016/j.tiv.2017.06.007
|
| 187 |
Lynn Hendrix, Mina Weakley. Animal Hospice and Palliative Medicine for the House Call Veterinarian. 2023; doi: 10.1016/B978-0-323-56798-5.00003-5
|
| 188 |
Cláudia Lobo, João Costa, Sara Petronilho, Paula Monteiro, Luís Leça, Fernando Schmitt. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Diagnostic Cytopathology 2021; 49(5) doi: 10.1002/dc.24440
|
| 189 |
Karol Polom, Luigi Marano, Giandomenico Roviello, Roberto Petrioli, Riccardo Piagnerelli, Lorenzo de Franco, Daniele Marrelli, Franco Roviello. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. International Journal of Hyperthermia 2016; 32(2) doi: 10.3109/02656736.2015.1111432
|
| 190 |
. 2021; doi: 10.70675/50ac5245z3ae5z4d7dz9192z123ef4fcbe01
|
| 191 |
Byungho Lim, Chan Kim, Jeong-Hwan Kim, Woo Sun Kwon, Won Seok Lee, Jeong Min Kim, Jun Yong Park, Hyo Song Kim, Kyu Hyun Park, Tae Soo Kim, Jong-Lyul Park, Hyun Cheol Chung, Sun Young Rha, Seon-Young Kim. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget 2016; 7(7) doi: 10.18632/oncotarget.6977
|
| 192 |
Chang Liu, Zhuanglong Xiao, Li Du, Shenghua Zhu, Hongyu Xiang, Zehui Wang, Fang Liu, Yuhu Song. Interferon-γ secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascites. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01312-5
|
| 193 |
Mehmet Ali Aslaner, Mahi Nur Cerit, Şaban Esen. Can Multi-organ Sonographic Parameters Predict Mortality in Patients With Acute Kidney Injury?. Journal of Diagnostic Medical Sonography 2024; 40(5) doi: 10.1177/87564793241234867
|
| 194 |
Rohit Joshi, Hooi Wen Hong. The MASCC Textbook of Cancer Supportive Care and Survivorship. 2018; doi: 10.1007/978-3-319-90990-5_29
|
| 195 |
Xiao Wu, Rana Rabei, Eric J. Keller, Bradley King, Nishita Kothary, Maureen Kohi, Andrew Taylor, Michael Heller. Tunneled Peritoneal Catheter vs Repeated Paracenteses for Recurrent Ascites: A Cost-Effectiveness Analysis. CardioVascular and Interventional Radiology 2022; 45(7) doi: 10.1007/s00270-022-03103-4
|
| 196 |
Margaret Y. Han, Erkut H. Borazanci. Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138759
|
| 197 |
Francisco Cezar Aquino de Moraes, Luis Henrique Rios Moreira Rego, Gustavo Tadeu Freitas Uchôa Matheus, Clara Rocha Dantas, Ana Luiza Marçalo de Tolosa, Rommel Mario Rodríguez Burbano, Mario Hiroyuki Hirata. Does Malignant Ascites Define Prognosis in Gastric Cancer with Peritoneal Spread? A Systematic Review and Meta-analysis. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01332-7
|
| 198 |
Mackenzie C. Morris, Jordan M. Cloyd, John Hays, Sameer H. Patel. The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies. Journal of Gastrointestinal Surgery 2021; 25(1) doi: 10.1007/s11605-020-04771-8
|
| 199 |
Mauricio Antonio Castaño Cárcamo, Angélica Viviana Fletcher Prieto. Terapia intraperitoneal paliativa en ascitis maligna refractaria. Revista Colombiana de Cancerología 2018; 22(1) doi: 10.1016/j.rccan.2017.01.001
|
| 200 |
Samuel Pau, Timothy Eglinton, Alan Wang, Jesse Fischer. Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors. European Journal of Surgical Oncology 2025; 51(12) doi: 10.1016/j.ejso.2025.110537
|
| 201 |
Lok Hang Chow, Annabelle M. Y. Ngai, Cheuk-yin Tang, Jacqueline H. S. Lee, Alfred L. H. Lee, Joshua J. X. Li, Philip P. C. Ip. Malignant ascites in ovarian cancer is compatible with long-term (10 year) survival with associations to clinicopathological features. Journal of Ovarian Research 2025; 18(1) doi: 10.1186/s13048-025-01657-8
|
| 202 |
Cristina Prata Amendola, Luís Gustavo Capochin Romagnolo, Raphael L. C. Araujo. Oncologic Critical Care. 2020; doi: 10.1007/978-3-319-74588-6_73
|
| 203 |
Basim M. Ali, Furqan Moein, Maha Al-Andaleb, Shaymaa Dhyaa. A field study dealing with biocmetrics of some clinical variables for hepatitis C patients. Al-Kufa University Journal for Biology 2021; 13(2) doi: 10.36320/ajb/v13.i2.11757
|
| 204 |
Fatemeh Movahedi, Li Li, Wenyi Gu, Zhi Ping Xu. Nanoformulations of Albendazole As Effective Anticancer and Antiparasite Agents. Nanomedicine 2017; 12(20) doi: 10.2217/nnm-2017-0102
|
| 205 |
Young Shin Shin, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Jin Kim, Mong Cho, Sun Hwi Hwang, Si Hak Lee. Factors associated with clinical failure of self-expandable metal stent for malignant gastroduodenal obstruction.. Scandinavian Journal of Gastroenterology 2016; 51(1) doi: 10.3109/00365521.2015.1064992
|
| 206 |
Chao-Cheng Chen, Jia-Je Li, Nai-Hua Guo, Deng-Yuan Chang, Chung-Yih Wang, Jenn-Tzong Chen, Wuu-Jyh Lin, Kwan-Hwa Chi, Yi-Jang Lee, Ren-Shyan Liu, Chuan-Lin Chen, Hsin-Ell Wang. Evaluation of the Biological Behavior of a Gold Nanocore-Encapsulated Human Serum Albumin Nanoparticle (Au@HSANP) in a CT-26 Tumor/Ascites Mouse Model after Intravenous/Intraperitoneal Administration. International Journal of Molecular Sciences 2019; 20(1) doi: 10.3390/ijms20010217
|
| 207 |
Jeffrey Maslanka, Gretel Torres, Jennifer Londregan, Naomi Goldman, Daniel Silberman, John Somerville, James E. Riggs. Loss of B1 and marginal zone B cells during ovarian cancer. Cellular Immunology 2024; doi: 10.1016/j.cellimm.2023.104788
|
| 208 |
Nada Oršolić, Snježana Ramić, Ivana Turk, Daniela Ančić. Mechanistic Biological Insights into the Effects of Resveratrol and Nano-Resveratrol on EAT-Induced Hepatorenal Damage. Nutrients 2026; 18(15) doi: 10.3390/nu18152444
|
| 209 |
Dimitrios K. Filippiadis, Evgenia Efthymiou, Athanasios Gianakis, George Charalampopoulos, Stavros Spiliopoulos. Cancer Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 2 doi: 10.1007/16833_2023_175
|
| 210 |
Clifford L.K. Pang, Xinting Zhang, Zhen Wang, Junwen Ou, Yimin Lu, Pengfei Chen, Changlin Zhao, Xiaopu Wang, Hongyu Zhang, Sergey V. Roussakow. Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial. Molecular and Clinical Oncology 2017; 6(5) doi: 10.3892/mco.2017.1221
|
| 211 |
Reese W. Randle, Katrina R. Swett, Douglas S. Swords, Perry Shen, John H. Stewart, Edward A. Levine, Konstantinos I. Votanopoulos. Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites. Annals of Surgical Oncology 2014; 21(5) doi: 10.1245/s10434-013-3224-y
|
| 212 |
Anusha Thadi, Marian Khalili, William Morano, Scott Richard, Steven Katz, Wilbur Bowne. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018; 6(3) doi: 10.3390/vaccines6030054
|
| 213 |
Katrin M. Sjoquist, David Espinoza, Linda Mileshkin, Sumitra Ananda, Catherine Shannon, Sonia Yip, Jeffrey Goh, David Bowtell, Michelle Harrison, Michael L. Friedlander. REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer. Gynecologic Oncology 2021; 161(2) doi: 10.1016/j.ygyno.2021.02.002
|
| 214 |
Lucely Marisel Fiscal Idrobo, Victoria Eugenia Salazar, Cindy Paola Oviedo Segura, Diana Milena Gavilán Martínez, Xiomara Carmona Montoya. Drenaje peritoneal como tratamiento de la ascitis maligna, una revisión de la literatura. Revista Cuidarte 2020; 11(1) doi: 10.15649/cuidarte.919
|
| 215 |
Suman Khadka, Diwakar Koirala, Ramesh Sapkota, Bivek Mishra, Dinesh Nalbo, Vijay Shrestha, Suresh Prasad Sah. Idiopathic postoperative intra-abdominal fluid collection with features of ascites following cesarean section: A rare case report. Medical Reports 2026; 18 doi: 10.1016/j.hmedic.2026.100460
|
| 216 |
Yu-Hua Shao, Chien-Chang Kao, Shou-Hung Tang, Tai-Lung Cha, Chih-Wei Tsao, En Meng, Dah-Shyong Yu, Guang-Huan Sun, Sheng-Tang Wu. Unusual presentation of direct intraperitoneal metastases complicated with massive ascites from plasmacytoid variant of bladder cancer and adenocarcinoma of colon. Medicine 2017; 96(7) doi: 10.1097/MD.0000000000005816
|
| 217 |
Yoshiko Kawata, Kazunori Nagasaka, Yoko Matsumoto, Katsutoshi Oda, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori-Uchino, Tetsushi Tsuruga, Takahide Arimoto, Yutaka Osuga, Tomoyuki Fujii. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites. International Journal of Clinical Oncology 2019; 24(4) doi: 10.1007/s10147-018-1371-7
|
| 218 |
Yujuan Li, Yang Yang, Aiwei Xiong, Xiaoqin Wu, Jingyan Xie, Suping Han, Shuli Zhao. Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00607
|
| 219 |
Jared A. Christensen, Nathan Loudon. Digestive Disease Interventions. 2026; doi: 10.1007/978-3-032-03935-4_34
|
| 220 |
Roy Hajjar, Manon Oliero, Gabriela Fragoso, Ayodeji Samuel Ajayi, Ahmed Amine Alaoui, Hervé Vennin Rendos, Annie Calvé, Thibault Cuisiniere, Claire Gerkins, Sophie Thérien, Nassima Taleb, François Dagbert, Herawaty Sebajang, Rasmy Loungnarath, Frank Schwenter, Richard Ratelle, Ramses Wassef, Eric De Broux, Carole Richard, Manuela M. Santos. Modulating Gut Microbiota Prevents Anastomotic Leak to Reduce Local Implantation and Dissemination of Colorectal Cancer Cells after Surgery. Clinical Cancer Research 2024; 30(3) doi: 10.1158/1078-0432.CCR-23-1601
|
| 221 |
Han Ho Jeon, Chan Hyuk Park, Jun Chul Park, Choong Nam Shim, Sunyong Kim, Hyun Jik Lee, Hyuk Lee, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee. Carcinomatosis matters: clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction. Surgical Endoscopy 2014; 28(3) doi: 10.1007/s00464-013-3268-x
|
| 222 |
Erin M. Sadler, Anand Govindarajan, Lucy K. Helyer, Alexandra M. Easson. Surgical Oncology Manual. 2020; doi: 10.1007/978-3-030-48363-0_20
|
| 223 |
Kanae Inoue, Koh Fukushi, Shota Yamaguchi, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda. Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. Pancreatology 2024; 24(4) doi: 10.1016/j.pan.2024.03.015
|
| 224 |
Xiaoli Gu, Yuanyuan Zhang, Menglei Cheng, Minghui Liu, Zhe Zhang, Wenwu Cheng. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage. BMC Palliative Care 2016; 15(1) doi: 10.1186/s12904-016-0116-5
|
| 225 |
Chao-Yu Chen, Li-Wen Lee, Tzu-Hao Huang, Yu-Che Ou, Chien-Hui Hung, Jrhau Lung, Yu-San Liao, Ting-Yao Wang, Lan-Yan Yang. Real-world risk factors for incomplete cytoreduction in peritoneal carcinomatosis patients scheduled for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03988-8
|
| 226 |
Etienne van Bracht, René Raavé, Igor Y. Perevyazko, Elly M. Versteeg, Theo G. Hafmans, Ulrich S. Schubert, Egbert Oosterwijk, Toin H. van Kuppevelt, Willeke F. Daamen. Biodistribution of size-selected lyophilisomes in mice. European Journal of Pharmaceutics and Biopharmaceutics 2015; 94 doi: 10.1016/j.ejpb.2015.04.020
|
| 227 |
Olanrewaju Samuel Balogun, Oluwole Ayoola Atoyebi. Management of Malignant Obstructive Jaundice. Journal of West African College of Surgeons 2022; 12(3) doi: 10.4103/jwas.jwas_22_22
|
| 228 |
Min Jin Jeong, Yeo Nyeong Yoon, Yeon Kyung Kang, Chan Joo Kim, Hae Seong Nam, Yong Seok Lee. A Novel Score Using Lymphocyte-to-Monocyte Ratio in Blood and Malignant Body Fluid for Predicting Prognosis of Patients with Advanced Ovarian Cancer. Cancers 2023; 15(8) doi: 10.3390/cancers15082328
|
| 229 |
Aurélie Balmer, Daniel Clerc, Laura Toussaint, Olivia Sgarbura, Abdelkader Taïbi, Martin Hübner, Hugo Teixeira Farinha. Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases. Cancers 2022; 14(10) doi: 10.3390/cancers14102557
|
| 230 |
Abhinav Sidana, Meet Kadakia, Julia C. Friend, Louis S. Krane, Daniel Su, Maria J. Merino, Ramaprasad Srinivasan. Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urologic Oncology: Seminars and Original Investigations 2017; 35(3) doi: 10.1016/j.urolonc.2016.10.023
|
| 231 |
Zhouwei Zhan, Xiaojie Wang, Jiami Yu, Jingxian Zheng, Yi Zeng, Mingyao Sun, Li Peng, Zengqing Guo, Bijuan Chen. Intraperitoneal Infusion of Recombinant Human Endostatin Improves Prognosis in Gastric Cancer Ascites. Future Oncology 2022; 18(10) doi: 10.2217/fon-2021-0896
|
| 232 |
Min Li, Dongxin Liang, Lanbo Zhao, Yiran Wang, Xin He, Wen Zhang, Tiantian Wang, Yadi Bin, Yu Liu, Ruining Ma, Zhe Yang, Siyi Zhang, Yuqi Wang, Qiling Li. Near-Infrared Fluorescent Zwitterionic Folic Acid Probe and Serum CA125 for Enhancing Diagnostic Accuracy of Malignant Ovarian Cancer Ascites. Technology in Cancer Research & Treatment 2026; 25 doi: 10.1177/15330338261488986
|
| 233 |
Kiran Iyer, Lucy Kernick, Duc Trong Quach. The Impact of ASCITIC Paracentesis on Symptomatic Outcomes in Palliative Patients: 3-Year Experience of a Melbourne Inpatient Palliative Care Unit Using Palliative Care Outcomes Collaboration Assessments. Gastroenterology Research and Practice 2022; 2022 doi: 10.1155/2022/7300110
|
| 234 |
Jens Krugmann, Corinna Lang Schwarz, Balint Melcher, William Sterlacci, Agne Ozalinskaite, Johannes Lermann, Abbas Agaimy, Michael Vieth. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006–2015. Archives of Gynecology and Obstetrics 2019; 299(2) doi: 10.1007/s00404-018-4952-9
|
| 235 |
Wei Suo, Xixing Wang, Cong Liu, Shilin He, Likun Liu, Shulan Hao. An Investigation into the Potential Therapeutic Effects of the Qigu
Zhushui Decoction on Mouse Models of Malignant Ascites. Combinatorial Chemistry & High Throughput Screening 2023; 26(15) doi: 10.2174/1386207326666230417095120
|
| 236 |
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells. Gastric Cancer 2023; 26(1) doi: 10.1007/s10120-022-01338-1
|
| 237 |
Simone Sibio, Joseph Maher Fouad Atta, Daniele Biacchi, Enzo Naticchioni, Maurizio Cardi. Treatment of Peritoneal Surface Malignancies. Updates in Surgery 2015; doi: 10.1007/978-88-470-5711-1_23
|
| 238 |
Alexey Bogdanov, Nikolay Verlov, Andrey Bogdanov, Vladimir Burdakov, Valeriy Semiletov, Vitaliy Egorenkov, Nikita Volkov, Vladimir Moiseyenko. Tumor alkalization therapy: misconception or good therapeutics perspective? – the case of malignant ascites. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1342802
|
| 239 |
Alfredo Toledo-Leyva, Julio César Villegas-Pineda, Sergio Encarnación-Guevara, Dolores Gallardo-Rincón, Patricia Talamás-Rohana. Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer. Proteome Science 2018; 16(1) doi: 10.1186/s12953-018-0133-9
|
| 240 |
Jack W Power, Philip J Dempsey, Andrew Yates, Helen Fenlon, Jurgen Mulsow, Conor Shields, Carmel G Cronin. Peritoneal malignancy: anatomy, pathophysiology and an update on modern day imaging. The British Journal of Radiology 2022; 95(1132) doi: 10.1259/bjr.20210217
|
| 241 |
|
| 242 |
Shuang Dong, Binlei Liu, Sheng Hu, Fang Guo, Yi Zhong, Qian Cai, Siqi Zhang, Yu Qian, Jun Wang, Fuxiang Zhou. A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer. Cancer Medicine 2022; 11(22) doi: 10.1002/cam4.4772
|
| 243 |
The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer 2020; 126(11) doi: 10.1002/cncr.32826
|
| 244 |
Keisuke Baba, Tomoki Tanie, Yasuo Matsubara, Yoshihiro Hirata, Hiroaki Ikematsu, Narikazu Boku. Reinfusion of Malignant Ascites through an Extracorporeal Peritoneal Venous Shunt to Avoid Complications and Assess the Safety of a Denver Shunt: A Case Report. Case Reports in Oncology 2025; 18(1) doi: 10.1159/000543892
|